Affiliation: LymeCare Alliance
Email: [email protected]
ORCID: 0009-0005-13886618
Collagen-rich tissues, such as skin, cartilage, and bones, present a major challenge in antimicrobial treatment due to their dense extracellular matrix and limited vascularization. Traditional antibiotics often struggle to penetrate these structures, leaving bacterial infections persistent and resistant. This study explores the potential of carvacrol, cinnamaldehyde, and eugenol—three natural antimicrobial compounds—to overcome these barriers. By analyzing their diffusion properties, enzymatic stability, and biofilm-disrupting abilities, I propose that nano-liposomal delivery systems could significantly enhance their penetration and therapeutic efficacy.
The persistence of Borrelia burgdorferi in Lyme disease patients is driven by biofilms, persister cells, and antibiotic resistance. This study explores how herbal extracts, essential oils, and antibiotics work together to enhance bacterial eradication, disrupt biofilms, and improve treatment outcomes for chronic Lyme disease.
Hyperbaric oxygen therapy (HBOT) and plasmapheresis are often discussed as alternative Lyme disease treatments, but do they work on their own? This article explores the scientific evidence, separating realistic potential from speculative claims.
Emerging clinical evidence demonstrates that the oral drug fenofibrate can directly stimulate nerve regeneration and reduce neuroinflammation. This article explores its promising application for treating persistent nerve damage following Lyme neuroborreliosis, a condition with currently limited therapeutic options.
